204 related articles for article (PubMed ID: 3498754)
1. T cell lineages in the thymus of lpr/lpr mice. Evidence for parallel pathways of normal and abnormal T cell development.
Budd RC; Schreyer M; Miescher GC; MacDonald HR
J Immunol; 1987 Oct; 139(7):2200-10. PubMed ID: 3498754
[TBL] [Abstract][Full Text] [Related]
2. Cultured Lyt-2- L3T4- T lymphocytes from normal thymus or lpr mice express a broad spectrum of cytolytic activity.
Budd RC; Cerottini JC; MacDonald HR
J Immunol; 1986 Dec; 137(12):3734-41. PubMed ID: 3491147
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the existence of two parallel differentiation pathways in the thymus of MRL lpr/lpr mice.
Matsuzaki Y; Pannetien C; Kanagawa O; Gachelin G; Nakauchi H
J Immunol; 1992 Aug; 149(3):1069-74. PubMed ID: 1378863
[TBL] [Abstract][Full Text] [Related]
4. Abnormal expression of T cell receptor genes in Lyt-2- L3T4- lymphocytes of lpr mice: comparison with normal immature thymocytes.
Miescher GC; Budd RC; Lees RK; MacDonald HR
J Immunol; 1987 Mar; 138(6):1959-67. PubMed ID: 3102607
[TBL] [Abstract][Full Text] [Related]
5. Paul-Bunnell antigen in murine T cell differentiation: abnormal expression in MRL/Mp-lpr/lpr mice.
Katagiri T; Tomiyama H; Kano K
J Immunol; 1986 Feb; 136(3):913-9. PubMed ID: 3079803
[TBL] [Abstract][Full Text] [Related]
6. Autoreactivity accelerates the development of autoimmunity and lymphoproliferation in MRL/Mp-lpr/lpr mice.
Weston KM; Yeh ET; Sy MS
J Immunol; 1987 Aug; 139(3):734-42. PubMed ID: 3110283
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of self-reactive T cell receptor V beta regions in autoimmune mice.
Mountz JD; Smith TM; Toth KS
J Immunol; 1990 Mar; 144(6):2159-66. PubMed ID: 1690237
[TBL] [Abstract][Full Text] [Related]
8. Expression of the J11d marker on peripheral T lymphocytes of MRL-lpr/lpr mice.
Seth A; Pyle RH; Nagarkatti M; Nagarkatti PS
J Immunol; 1988 Aug; 141(4):1120-5. PubMed ID: 2899601
[TBL] [Abstract][Full Text] [Related]
9. Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice. Clues from a T cell receptor beta transgenic mouse.
Zhou T; Bluethmann H; Eldridge J; Berry K; Mountz JD
J Immunol; 1993 Apr; 150(8 Pt 1):3651-67. PubMed ID: 7682246
[TBL] [Abstract][Full Text] [Related]
10. Oncogene expression in autoimmune mice.
Mountz JD; Mushinski JF; Mark GE; Steinberg AD
J Mol Cell Immunol; 1985; 2(3):121-31. PubMed ID: 3916923
[TBL] [Abstract][Full Text] [Related]
11. In CD8+ T cell-deficient lpr/lpr mice, CD4+B220+ and CD4+B220- T cells replace B220+ double-negative T cells as the predominant populations in enlarged lymph nodes.
Giese T; Davidson WF
J Immunol; 1995 May; 154(10):4986-95. PubMed ID: 7537297
[TBL] [Abstract][Full Text] [Related]
12. CD2-CD4-CD8- lymph node T lymphocytes in MRL lpr/lpr mice are derived from a CD2+CD4+CD8+ thymic precursor.
Landolfi MM; Van Houten N; Russell JQ; Scollay R; Parnes JR; Budd RC
J Immunol; 1993 Jul; 151(2):1086-96. PubMed ID: 7687614
[TBL] [Abstract][Full Text] [Related]
13. Unique surface phenotype of T cells in lymphoproliferative autoimmune MRL/Mp-lpr/lpr mice.
Takei F
J Immunol; 1984 Oct; 133(4):1951-4. PubMed ID: 6332141
[TBL] [Abstract][Full Text] [Related]
14. T cell receptor gene expression in autoimmune mice.
Mountz JD; Huppi KE; Seldin MF; Mushinski JF; Steinberg AD
J Immunol; 1986 Aug; 137(3):1029-36. PubMed ID: 3487582
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic, functional, and molecular genetic comparisons of the abnormal lymphoid cells of C3H-lpr/lpr and C3H-gld/gld mice.
Davidson WF; Dumont FJ; Bedigian HG; Fowlkes BJ; Morse HC
J Immunol; 1986 Jun; 136(11):4075-84. PubMed ID: 3009614
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis of elevated c-myb expression in the abnormal L3T4-, Lyt-2- T lymphocytes of autoimmune mice.
Evans JL; Boyle WJ; Ting JP
J Immunol; 1987 Nov; 139(10):3497-505. PubMed ID: 3316384
[TBL] [Abstract][Full Text] [Related]
17. IL-2 receptor expression in autoimmune MRL-lpr/lpr mice. The expanded L3T4-, Lyt-2- population does not express p75 and cannot generate functional high-affinity IL-2 receptors.
Rosenberg YJ; Nurse F; Begley CG
J Immunol; 1989 Oct; 143(7):2216-22. PubMed ID: 2789257
[TBL] [Abstract][Full Text] [Related]
18. Influence of the lpr environment on the lymph node cell phenotypes in C57BL/6 nubg and nulpr chimeras.
Tiberghien F; Ceredig R; Loor F
Immunology; 1994 Dec; 83(4):552-61. PubMed ID: 7875735
[TBL] [Abstract][Full Text] [Related]
19. Growth and differentiation in vitro of the accumulating Lyt-2-/L3T4- subset in lpr mice.
Budd RC; MacDonald HR; Lowenthal JW; Davignon JL; Izui S; Cerottini JC
J Immunol; 1985 Dec; 135(6):3704-11. PubMed ID: 3934265
[TBL] [Abstract][Full Text] [Related]
20. CS-A therapy in MRL-lpr/lpr mice: amelioration of immunopathology despite autoantibody production.
Mountz JD; Smith HR; Wilder RL; Reeves JP; Steinberg AD
J Immunol; 1987 Jan; 138(1):157-63. PubMed ID: 3537128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
